TMO

#69
Thermo Fisher Scientific, Inc.
510.71 USD
+2.95%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
510.07
511.08
Jahresspanne
385.46
643.99
Tagesänderung
+2.95%
Monatliche Änderung
+8.57%
6 month change
-2.17%
Jahresänderung
+14.12%
Vorheriger Schlusskurs
496.09
Eröffnung
510.64
Bid
Ask
Tief
510.07
High
511.08
Volumen
414
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik Dividenden
Vierteljährlich Jährlich
  • Market Capitalization 189.72 B
  • Employee 125 K
  • Founded N/A
  • CEO Marc N. Casper
  • Website www.thermofisher.com
  • Headquarter Delaware, United States
  • FIGI BBG000BVDLH9
  • Industry Technology
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Kurs-Gewinn-Verhältnis
32.66
Preis-Umsatz-Verhältnis
4.92
Dividende je Aktie
1.72
Dividendenrendite in %
0.3

Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation, Alfa Aesar, Affymetrix, FEI Company, BD Advanced Bioprocessing, and PPD. It ranked 104th on the Fortune 500 list based on its 2024 annual revenue of $42.879 billion. Thermo Fisher announced a $2 billion investment over four years in the U.S., including $1.5 billion for expanding manufacturing capacity and $500 million for R&D investment. This initiative aims to bolster domestic biotech manufacturing, create high-paying jobs, and reinforce the U.S. healthcare supply chain.

Nachrichten